Baxter (BAX) Stock Forecast, Price Target & Predictions
BAX Stock Forecast
Baxter stock forecast is as follows: an average price target of $64.62 (represents a 62.69% upside from BAX’s last price of $39.72) and a rating consensus of 'Hold', based on 24 wall street analysts offering a 1-year stock forecast.
BAX Price Target
The average price target for Baxter (BAX) is $64.62 based on 1-year price targets from 24 Wall Street analysts in the past 3 months, with a price target range of $100.00 to $30.00. This represents a potential 62.69% upside from BAX's last price of $39.72.
BAX Analyst Ratings
According to 24 Wall Street analysts, Baxter's rating consensus is 'Hold'. The analyst rating breakdown for BAX stock is 0 'Strong Buy' (0.00%), 10 'Buy' (41.67%), 13 'Hold' (54.17%), 1 'Sell' (4.17%), and 0 'Strong Sell' (0.00%).
Baxter Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 06, 2024 | Matthew Taylor | Jefferies | $42.00 | $36.92 | 13.76% | 5.74% |
| Jul 15, 2024 | Patrick Wood | Morgan Stanley | $30.00 | $35.32 | -15.06% | -24.47% |
| Jun 12, 2024 | David Roman | Goldman Sachs | $36.00 | $33.31 | 8.08% | -9.37% |
| May 03, 2024 | Danielle Antalffy | UBS | $40.00 | $36.91 | 8.37% | 0.70% |
| May 02, 2024 | Matthew Taylor | Jefferies | $43.00 | $36.89 | 16.56% | 8.26% |
| May 02, 2024 | Rick Wise | Stifel Nicolaus | $44.00 | $36.73 | 19.81% | 10.78% |
| Jul 31, 2023 | Matt Miksic | Barclays | $54.00 | $45.26 | 19.32% | 35.95% |
| Jul 31, 2023 | Philippe Houchois | Jefferies | $85.00 | $47.01 | 80.81% | 114.00% |
| Mar 27, 2023 | Joanne Wuensch | Citigroup | $44.00 | $39.71 | 10.80% | 10.78% |
| Apr 29, 2022 | - | Raymond James | $85.00 | $70.35 | 20.82% | 114.00% |
The latest Baxter stock forecast, released on Aug 06, 2024 by Matthew Taylor from Jefferies, set a price target of $42.00, which represents a 13.76% increase from the stock price at the time of the forecast ($36.92), and a 5.74% increase from BAX last price ($39.72).
Baxter Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 6 |
| Avg Price Target | - | $36.00 | $39.17 |
| Last Closing Price | $39.72 | $39.72 | $39.72 |
| Upside/Downside | -100.00% | -9.37% | -1.38% |
In the current month, the average price target of Baxter stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Baxter's last price of $39.72. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 06, 2024 | Jefferies | Hold | Hold | Hold |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| Jun 12, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
| May 30, 2024 | Goldman Sachs | Buy | Neutral | Initialise |
| May 22, 2024 | Citigroup | Neutral | Neutral | Hold |
| May 10, 2024 | Cowen & Co. | Sector Weight | Hold | Downgrade |
| May 03, 2024 | UBS | Neutral | Neutral | Hold |
| May 02, 2024 | Jefferies | Hold | Hold | Hold |
| Apr 03, 2024 | Citigroup | Neutral | Neutral | Hold |
| Feb 12, 2024 | Barclays | Overweight | Overweight | Hold |
Baxter's last stock rating was published by Jefferies on Aug 06, 2024. The company gave BAX a "Hold" rating, the same as its previous rate.
Baxter Financial Forecast
Baxter Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $3.71B | $3.71B | $3.65B | $3.89B | $3.77B | - | $3.71B | $3.51B | $3.23B | $3.10B | $2.95B | $3.18B | $2.97B | $2.72B | $2.80B | $3.04B | $2.85B | $2.84B | $2.63B | $2.84B | $2.77B |
| Avg Forecast | $4.13B | $3.96B | $3.93B | $3.71B | $3.98B | $3.84B | $3.75B | $3.55B | $3.81B | $3.70B | $3.79B | $3.60B | $3.77B | $3.77B | $3.88B | $3.68B | $3.30B | $3.23B | $3.11B | $2.90B | $3.12B | $2.83B | $2.87B | $2.73B | $3.04B | $2.86B | $2.79B | $2.61B | $2.65B | $2.56B |
| High Forecast | $4.15B | $3.97B | $3.95B | $3.73B | $4.00B | $3.86B | $3.77B | $3.57B | $3.82B | $3.78B | $3.80B | $3.62B | $3.78B | $3.78B | $3.88B | $3.70B | $3.32B | $3.25B | $3.13B | $2.92B | $3.14B | $2.85B | $2.89B | $2.75B | $3.06B | $2.88B | $2.81B | $2.63B | $3.18B | $3.07B |
| Low Forecast | $4.10B | $3.93B | $3.90B | $3.69B | $3.95B | $3.83B | $3.73B | $3.53B | $3.78B | $3.67B | $3.76B | $3.58B | $3.74B | $3.74B | $3.88B | $3.64B | $3.27B | $3.19B | $3.08B | $2.87B | $3.09B | $2.80B | $2.84B | $2.71B | $3.01B | $2.83B | $2.76B | $2.58B | $2.12B | $2.05B |
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 7 | 10 | 9 | 9 | 8 | 8 | 4 | 4 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 13 |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.00% | 0.98% | 1.01% | 1.03% | 1.00% | - | 1.01% | 1.06% | 1.00% | 1.00% | 1.02% | 1.02% | 1.05% | 0.95% | 1.02% | 1.00% | 1.00% | 1.02% | 1.01% | 1.07% | 1.08% |
Baxter's average Quarter revenue forecast for Dec 23 based on 7 analysts is $3.81B, with a low forecast of $3.78B, and a high forecast of $3.82B. BAX's average Quarter revenue forecast represents a 2.65% increase compared to the company's last Quarter revenue of $3.71B (Sep 23).
Baxter EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 7 | 10 | 9 | 9 | 8 | 8 | 4 | 4 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 13 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-51.00M | $-1.00M | $187.00M | $368.00M | $265.00M | - | $534.00M | $602.00M | $709.00M | $648.00M | $603.00M | $461.00M | $663.00M | $530.00M | $605.00M | $12.00M | $690.00M | $589.00M | $611.00M | $653.00M | $637.00M |
| Avg Forecast | $481.61M | $461.23M | $457.80M | $432.86M | $463.81M | $447.97M | $437.64M | $567.49M | $443.65M | $430.92M | $441.22M | $515.90M | $439.06M | $713.53M | $452.02M | $469.00M | $596.16M | $648.66M | $595.46M | $500.95M | $436.74M | $572.18M | $582.25M | $520.97M | $354.21M | $772.14M | $530.83M | $539.12M | $608.27M | $585.35M |
| High Forecast | $483.74M | $463.27M | $459.83M | $434.78M | $465.86M | $450.30M | $439.58M | $680.99M | $444.81M | $440.03M | $443.17M | $619.08M | $441.01M | $856.23M | $452.02M | $562.80M | $715.39M | $778.39M | $714.55M | $601.14M | $524.08M | $686.61M | $698.70M | $625.17M | $356.74M | $926.57M | $636.99M | $646.94M | $729.93M | $702.42M |
| Low Forecast | $478.23M | $457.99M | $454.58M | $429.82M | $460.54M | $446.80M | $434.57M | $453.99M | $440.14M | $427.53M | $438.12M | $412.72M | $435.98M | $570.82M | $452.02M | $375.20M | $476.92M | $518.93M | $476.37M | $400.76M | $349.39M | $457.74M | $465.80M | $416.78M | $350.65M | $617.71M | $424.66M | $431.29M | $486.62M | $468.28M |
| Surprise % | - | - | - | - | - | - | - | - | - | -0.12% | -0.00% | 0.36% | 0.84% | 0.37% | - | 1.14% | 1.01% | 1.09% | 1.09% | 1.20% | 1.06% | 1.16% | 0.91% | 1.16% | 0.03% | 0.89% | 1.11% | 1.13% | 1.07% | 1.09% |
9 analysts predict BAX's average Quarter EBITDA for Jun 23 to be $441.22M, with a high of $443.17M and a low of $438.12M. This is 135.95% upper than Baxter's previous annual EBITDA (Mar 23) of $187.00M.
Baxter Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 7 | 10 | 9 | 9 | 8 | 8 | 4 | 4 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 13 |
| Net Income | - | - | - | - | - | - | - | - | - | $2.51B | $-141.00M | $44.00M | $181.00M | $-2.93B | - | $71.00M | $242.00M | $450.00M | $298.00M | $298.00M | $168.00M | $356.00M | $246.00M | $331.00M | $-23.00M | $369.00M | $343.00M | $347.00M | $348.00M | $544.00M |
| Avg Forecast | $457.01M | $416.01M | $393.40M | $360.06M | $443.26M | $396.10M | $337.83M | $71.95M | $440.83M | $340.21M | $305.79M | $65.41M | $479.13M | $452.87M | $445.49M | $59.46M | $235.69M | $411.70M | $273.84M | $247.57M | $159.16M | $307.23M | $270.25M | $285.03M | $449.91M | $412.93M | $309.12M | $306.18M | $324.16M | $499.89M |
| High Forecast | $459.64M | $418.40M | $395.67M | $362.13M | $445.81M | $398.38M | $339.77M | $86.34M | $445.95M | $395.24M | $307.55M | $78.49M | $481.89M | $543.45M | $445.49M | $71.36M | $282.83M | $494.04M | $328.61M | $297.08M | $190.99M | $368.68M | $324.30M | $342.03M | $454.09M | $495.51M | $370.95M | $367.41M | $389.00M | $599.87M |
| Low Forecast | $452.83M | $412.21M | $389.81M | $356.77M | $439.21M | $391.02M | $334.74M | $57.56M | $435.70M | $330.20M | $302.99M | $52.33M | $474.75M | $362.30M | $445.49M | $47.57M | $188.55M | $329.36M | $219.07M | $198.06M | $127.33M | $245.79M | $216.20M | $228.02M | $444.02M | $330.34M | $247.30M | $244.94M | $259.33M | $399.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | 7.37% | -0.46% | 0.67% | 0.38% | -6.48% | - | 1.19% | 1.03% | 1.09% | 1.09% | 1.20% | 1.06% | 1.16% | 0.91% | 1.16% | -0.05% | 0.89% | 1.11% | 1.13% | 1.07% | 1.09% |
Baxter's average Quarter net income forecast for Dec 23 is $440.83M, with a range of $435.70M to $445.95M. BAX's average Quarter net income forecast represents a -82.42% decrease compared to the company's last Quarter net income of $2.51B (Sep 23).
Baxter SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 7 | 10 | 9 | 9 | 8 | 8 | 4 | 4 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 13 |
| SG&A | - | - | - | - | - | - | - | - | - | $1.00B | $964.00M | $1.01B | $912.00M | $942.00M | - | $1.05B | $896.00M | $680.00M | $678.00M | $627.00M | $696.00M | $601.00M | $590.00M | $628.00M | $1.42B | $627.00M | $642.00M | $584.00M | $620.00M | $672.00M |
| Avg Forecast | $1.03B | $985.77M | $978.44M | $925.14M | $991.28M | $957.43M | $935.36M | $1.07B | $948.20M | $921.00M | $943.01M | $969.15M | $938.40M | $684.34M | $966.09M | $881.05M | $887.30M | $622.13M | $623.03M | $520.89M | $659.37M | $518.67M | $648.17M | $540.78M | $757.04M | $701.64M | $578.59M | $515.29M | $577.53M | $617.51M |
| High Forecast | $1.03B | $990.13M | $982.77M | $929.24M | $995.67M | $962.42M | $939.50M | $1.28B | $950.69M | $940.46M | $947.18M | $1.16B | $942.56M | $821.21M | $966.09M | $1.06B | $1.06B | $746.55M | $747.63M | $625.07M | $791.24M | $622.41M | $777.80M | $648.93M | $762.46M | $841.97M | $694.31M | $618.35M | $693.04M | $741.02M |
| Low Forecast | $1.02B | $978.84M | $971.57M | $918.64M | $984.31M | $954.94M | $928.79M | $852.86M | $940.71M | $913.76M | $936.38M | $775.32M | $931.81M | $547.47M | $966.09M | $704.84M | $709.84M | $497.70M | $498.42M | $416.71M | $527.49M | $414.94M | $518.54M | $432.62M | $749.43M | $561.31M | $462.87M | $412.24M | $462.03M | $494.01M |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.09% | 1.02% | 1.04% | 0.97% | 1.38% | - | 1.19% | 1.01% | 1.09% | 1.09% | 1.20% | 1.06% | 1.16% | 0.91% | 1.16% | 1.88% | 0.89% | 1.11% | 1.13% | 1.07% | 1.09% |
Baxter's average Quarter SG&A projection for Dec 23 is $948.20M, based on 7 Wall Street analysts, with a range of $940.71M to $950.69M. The forecast indicates a -5.37% fall compared to BAX last annual SG&A of $1.00B (Sep 23).
Baxter EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 7 | 10 | 9 | 9 | 8 | 8 | 4 | 4 | 5 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 13 |
| EPS | - | - | - | - | - | - | - | - | - | $4.95 | $-0.28 | $0.09 | $0.36 | $-5.82 | - | $0.14 | $0.48 | $0.90 | $0.59 | $0.59 | $0.33 | $0.70 | $0.48 | $0.65 | $-0.05 | $0.72 | $0.67 | $0.68 | $0.66 | $1.02 |
| Avg Forecast | $0.90 | $0.82 | $0.77 | $0.71 | $0.87 | $0.78 | $0.66 | $0.61 | $0.86 | $0.67 | $0.60 | $0.49 | $0.94 | $0.82 | $0.87 | $0.80 | $1.03 | $0.94 | $0.75 | $0.65 | $0.76 | $0.73 | $0.70 | $0.73 | $0.89 | $0.84 | $0.81 | $0.68 | $0.68 | $0.68 |
| High Forecast | $0.90 | $0.82 | $0.78 | $0.71 | $0.87 | $0.78 | $0.67 | $0.61 | $0.87 | $0.77 | $0.60 | $0.50 | $0.94 | $0.82 | $0.87 | $0.81 | $1.04 | $0.95 | $0.76 | $0.65 | $0.76 | $0.73 | $0.71 | $0.74 | $0.90 | $0.84 | $0.82 | $0.69 | $0.82 | $0.82 |
| Low Forecast | $0.89 | $0.81 | $0.76 | $0.70 | $0.86 | $0.77 | $0.66 | $0.60 | $0.85 | $0.65 | $0.59 | $0.49 | $0.93 | $0.81 | $0.87 | $0.79 | $1.01 | $0.93 | $0.74 | $0.64 | $0.75 | $0.72 | $0.70 | $0.72 | $0.88 | $0.83 | $0.80 | $0.67 | $0.54 | $0.54 |
| Surprise % | - | - | - | - | - | - | - | - | - | 7.42% | -0.47% | 0.18% | 0.38% | -7.14% | - | 0.17% | 0.47% | 0.96% | 0.79% | 0.91% | 0.44% | 0.96% | 0.68% | 0.89% | -0.05% | 0.86% | 0.82% | 1.00% | 0.97% | 1.50% |
According to 7 Wall Street analysts, Baxter's projected average Quarter EPS for Dec 23 is $0.86, with a low estimate of $0.85 and a high estimate of $0.87. This represents a -82.54% decrease compared to BAX previous annual EPS of $4.95 (Sep 23).
Baxter Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $110.53 | $298.00 | 169.61% | Buy |
| BAX | Baxter | $39.72 | $64.62 | 62.69% | Hold |
| TFX | Teleflex | $246.05 | $304.09 | 23.59% | Buy |
| NVST | Envista | $19.41 | $23.83 | 22.77% | Hold |
| BDX | Becton, Dickinson and Company | $234.18 | $280.55 | 19.80% | Buy |
| WST | West Pharmaceutical Services | $300.67 | $345.33 | 14.85% | Buy |
| HOLX | Hologic | $81.15 | $78.92 | -2.75% | Buy |
| MMSI | Merit Medical Systems | $96.16 | $93.38 | -2.89% | Buy |
| ALC | Alcon | $98.50 | $93.34 | -5.24% | Buy |
| RMD | ResMed | $248.93 | $209.33 | -15.91% | Hold |
| ICUI | ICU Medical | $179.00 | $135.00 | -24.58% | Buy |
| EMBC | Embecta | $16.02 | $12.00 | -25.09% | Sell |
BAX Forecast FAQ
Is Baxter a good buy?
No, according to 24 Wall Street analysts, Baxter (BAX) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 41.67% of BAX's total ratings.
What is BAX's price target?
Baxter (BAX) average price target is $64.62 with a range of $30 to $100, implying a 62.69% from its last price of $39.72. The data is based on 24 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Baxter stock go up soon?
According to Wall Street analysts' prediction for BAX stock, the company can go up by 62.69% (from the last price of $39.72 to the average price target of $64.62), up by 151.76% based on the highest stock price target, and down by -24.47% based on the lowest stock price target.
Can Baxter stock reach $60?
BAX's average twelve months analyst stock price target of $64.62 supports the claim that Baxter can reach $60 in the near future.
What are Baxter's analysts' financial forecasts?
Baxter's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $15.13B (high $15.2B, low $15.04B), average EBITDA is $1.92B (high $2.04B, low $1.8B), average net income is $1.25B (high $1.27B, low $1.22B), average SG&A $3.95B (high $4.18B, low $3.72B), and average EPS is $2.92 (high $2.93, low $2.89). BAX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $15.73B (high $15.8B, low $15.62B), average EBITDA is $1.83B (high $1.84B, low $1.82B), average net income is $1.63B (high $1.64B, low $1.61B), average SG&A $3.92B (high $3.94B, low $3.89B), and average EPS is $3.19 (high $3.21, low $3.16).
Did the BAX's actual financial results beat the analysts' financial forecasts?
Based on Baxter's last annual report (Dec 2022), the company's revenue was $15.11B, beating the average analysts forecast of $15.09B by 0.16%. Apple's EBITDA was $854M, missing the average prediction of $2.07B by -58.82%. The company's net income was $-2.421B, missing the average estimation of $1.44B by -268.48%. Apple's SG&A was $3.89B, beating the average forecast of $3.47B by 12.02%. Lastly, the company's EPS was $-4.8, missing the average prediction of $3.43 by -239.97%. In terms of the last quarterly report (Sep 2023), Baxter's revenue was $3.71B, beating the average analysts' forecast of $3.7B by 0.29%. The company's EBITDA was $-51M, missing the average prediction of $430.92M by -111.84%. Baxter's net income was $2.51B, beating the average estimation of $340.21M by 637.19%. The company's SG&A was $1B, beating the average forecast of $921M by 8.80%. Lastly, the company's EPS was $4.95, beating the average prediction of $0.667 by 642.04%